Annual Accounts Receivable
$10.35 B
+$899.00 M+9.51%
31 December 2023
Summary:
Merck & Co annual accounts receivable is currently $10.35 billion, with the most recent change of +$899.00 million (+9.51%) on 31 December 2023. During the last 3 years, it has risen by +$3.55 billion (+52.12%). MRK annual accounts receivable is now at all-time high.MRK Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$11.38 B
-$261.00 M-2.24%
30 September 2024
Summary:
Merck & Co quarterly accounts receivable is currently $11.38 billion, with the most recent change of -$261.00 million (-2.24%) on 30 September 2024. Over the past year, it has increased by +$987.00 million (+9.50%). MRK quarterly accounts receivable is now -2.24% below its all-time high of $11.64 billion, reached on 30 June 2024.MRK Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.5% | +9.5% |
| 3 y3 years | +52.1% | +32.8% |
| 5 y5 years | +46.4% | +34.8% |
MRK Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +52.1% | -2.2% | +32.8% |
| 5 y | 5 years | at high | +52.7% | -2.2% | +67.9% |
| alltime | all time | at high | +255.9% | -2.2% | +291.4% |
Merck & Co Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.38 B(-2.2%) |
| June 2024 | - | $11.64 B(+2.4%) |
| Mar 2024 | - | $11.37 B(+9.8%) |
| Dec 2023 | $10.35 B(+9.5%) | $10.35 B(-0.4%) |
| Sept 2023 | - | $10.39 B(-5.8%) |
| June 2023 | - | $11.03 B(+5.9%) |
| Mar 2023 | - | $10.41 B(+10.2%) |
| Dec 2022 | $9.45 B(+2.4%) | $9.45 B(-0.3%) |
| Sept 2022 | - | $9.48 B(-1.7%) |
| June 2022 | - | $9.64 B(-1.9%) |
| Mar 2022 | - | $9.83 B(+6.5%) |
| Dec 2021 | $9.23 B(+35.7%) | $9.23 B(+7.7%) |
| Sept 2021 | - | $8.57 B(+9.3%) |
| June 2021 | - | $7.84 B(-4.8%) |
| Mar 2021 | - | $8.23 B(+21.0%) |
| Dec 2020 | $6.80 B(+0.4%) | $6.80 B(-19.2%) |
| Sept 2020 | - | $8.42 B(+11.2%) |
| June 2020 | - | $7.58 B(-7.4%) |
| Mar 2020 | - | $8.18 B(+20.7%) |
| Dec 2019 | $6.78 B(-4.1%) | $6.78 B(-19.7%) |
| Sept 2019 | - | $8.44 B(+6.0%) |
| June 2019 | - | $7.96 B(+4.7%) |
| Mar 2019 | - | $7.61 B(+7.6%) |
| Dec 2018 | $7.07 B(+2.9%) | $7.07 B(-4.1%) |
| Sept 2018 | - | $7.37 B(+1.2%) |
| June 2018 | - | $7.29 B(+0.6%) |
| Mar 2018 | - | $7.25 B(+5.4%) |
| Dec 2017 | $6.87 B(-2.1%) | $6.87 B(-10.4%) |
| Sept 2017 | - | $7.67 B(+3.1%) |
| June 2017 | - | $7.44 B(+5.3%) |
| Mar 2017 | - | $7.07 B(+0.7%) |
| Dec 2016 | $7.02 B(+8.2%) | $7.02 B(-4.7%) |
| Sept 2016 | - | $7.36 B(+6.5%) |
| June 2016 | - | $6.92 B(+1.0%) |
| Mar 2016 | - | $6.85 B(+5.6%) |
| Dec 2015 | $6.48 B(-2.1%) | $6.48 B(+1.1%) |
| Sept 2015 | - | $6.41 B(-1.5%) |
| June 2015 | - | $6.51 B(-2.4%) |
| Mar 2015 | - | $6.67 B(+0.7%) |
| Dec 2014 | $6.63 B(-7.8%) | $6.63 B(+1.7%) |
| Sept 2014 | - | $6.51 B(-7.2%) |
| June 2014 | - | $7.02 B(-2.3%) |
| Mar 2014 | - | $7.19 B(+0.1%) |
| Dec 2013 | $7.18 B(-6.4%) | $7.18 B(-5.2%) |
| Sept 2013 | - | $7.58 B(-2.6%) |
| June 2013 | - | $7.78 B(-2.3%) |
| Mar 2013 | - | $7.96 B(+3.8%) |
| Dec 2012 | $7.67 B(-7.1%) | $7.67 B(-3.5%) |
| Sept 2012 | - | $7.95 B(-2.5%) |
| June 2012 | - | $8.15 B(-6.6%) |
| Mar 2012 | - | $8.73 B(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $8.26 B(+12.5%) | $8.26 B(+1.5%) |
| Sept 2011 | - | $8.14 B(-4.0%) |
| June 2011 | - | $8.47 B(+6.5%) |
| Mar 2011 | - | $7.96 B(+8.3%) |
| Dec 2010 | $7.34 B(+11.2%) | $7.34 B(+17.0%) |
| June 2010 | - | $6.28 B(-16.3%) |
| Mar 2010 | - | $7.50 B(+13.5%) |
| Dec 2009 | $6.60 B(+127.1%) | $6.60 B(+73.6%) |
| Sept 2009 | - | $3.80 B(+3.8%) |
| June 2009 | - | $3.66 B(+2.6%) |
| Mar 2009 | - | $3.57 B(+22.8%) |
| Dec 2008 | $2.91 B(-20.0%) | $2.91 B(-20.2%) |
| Sept 2008 | - | $3.64 B(-0.1%) |
| June 2008 | - | $3.65 B(-3.0%) |
| Mar 2008 | - | $3.76 B(+3.4%) |
| Dec 2007 | $3.64 B(+9.7%) | $3.64 B(+3.8%) |
| Sept 2007 | - | $3.50 B(-2.9%) |
| June 2007 | - | $3.61 B(-10.2%) |
| Mar 2007 | - | $4.02 B(+21.2%) |
| Dec 2006 | $3.31 B(+13.2%) | $3.31 B(+7.6%) |
| Sept 2006 | - | $3.08 B(-0.1%) |
| June 2006 | - | $3.08 B(+1.4%) |
| Mar 2006 | - | $3.04 B(+3.9%) |
| Dec 2005 | $2.93 B(-19.3%) | $2.93 B(-19.7%) |
| Sept 2005 | - | $3.65 B(+4.0%) |
| June 2005 | - | $3.51 B(-7.7%) |
| Mar 2005 | - | $3.80 B(+4.7%) |
| Dec 2004 | $3.63 B(-9.8%) | $3.63 B(-7.2%) |
| Sept 2004 | - | $3.91 B(+0.5%) |
| June 2004 | - | $3.89 B(-7.4%) |
| Mar 2004 | - | $4.20 B(+4.4%) |
| Dec 2003 | $4.02 B(-25.8%) | $4.02 B(-11.8%) |
| Sept 2003 | - | $4.56 B(-22.7%) |
| June 2003 | - | $5.90 B(+5.1%) |
| Mar 2003 | - | $5.62 B(+3.6%) |
| Dec 2002 | $5.42 B(+4.0%) | $5.42 B(-1.8%) |
| Sept 2002 | - | $5.52 B(-4.5%) |
| June 2002 | - | $5.79 B(+4.0%) |
| Mar 2002 | - | $5.57 B(+6.7%) |
| Dec 2001 | $5.22 B(+3.9%) | $5.22 B(-5.7%) |
| Sept 2001 | - | $5.53 B(+5.4%) |
| June 2001 | - | $5.25 B(+4.8%) |
| Mar 2001 | - | $5.01 B(-0.2%) |
| Dec 2000 | $5.02 B(+22.7%) | $5.02 B(+9.8%) |
| Sept 2000 | - | $4.57 B(+18.3%) |
| June 2000 | - | $3.86 B(+4.6%) |
| Mar 2000 | - | $3.69 B(-9.7%) |
| Dec 1999 | $4.09 B(+21.2%) | $4.09 B(+16.9%) |
| Sept 1999 | - | $3.50 B(+3.5%) |
| June 1999 | - | $3.38 B(+7.9%) |
| Mar 1999 | - | $3.13 B(-7.2%) |
| Dec 1998 | $3.37 B | $3.37 B |
FAQ
- What is Merck & Co annual accounts receivable?
- What is the all time high annual accounts receivable for Merck & Co?
- What is Merck & Co annual accounts receivable year-on-year change?
- What is Merck & Co quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Merck & Co?
- What is Merck & Co quarterly accounts receivable year-on-year change?
What is Merck & Co annual accounts receivable?
The current annual accounts receivable of MRK is $10.35 B
What is the all time high annual accounts receivable for Merck & Co?
Merck & Co all-time high annual accounts receivable is $10.35 B
What is Merck & Co annual accounts receivable year-on-year change?
Over the past year, MRK annual accounts receivable has changed by +$899.00 M (+9.51%)
What is Merck & Co quarterly accounts receivable?
The current quarterly accounts receivable of MRK is $11.38 B
What is the all time high quarterly accounts receivable for Merck & Co?
Merck & Co all-time high quarterly accounts receivable is $11.64 B
What is Merck & Co quarterly accounts receivable year-on-year change?
Over the past year, MRK quarterly accounts receivable has changed by +$987.00 M (+9.50%)